PharmaCyte Biotech/$PMCB
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About PharmaCyte Biotech
PharmaCyte Biotech Inc is a biotechnology company focused on developing cellular therapies for cancer based on its proprietary cellulose-based live cell encapsulation technology, Cell-in-a-Box. The technology is intended to be used as a platform for therapies for several types of cancer, including locally advanced, inoperable pancreatic cancer (LAPC). The current generation of the Company's product candidate is CypCaps. The Company is preparing to commercialize cellular therapies for cancer and advance clinical research and development, including a clinical trial in LAPC using encapsulated live cells. Its candidate therapy involves encapsulating genetically engineered human cells that convert an inactive chemotherapy drug into its active, cancer-killing form.
Ticker
$PMCB
Sector
Primary listing
Employees
2
Headquarters
Website
PMCB Metrics
BasicAdvanced
$6.2m
-
-$2.77
-
-
Price and volume
Market cap
$6.2m
52-week high
$1.51
52-week low
$0.55
Average daily volume
114k
Financial strength
Current ratio
45.28
Quick ratio
45.163
Profitability
Management effectiveness
Return on assets (TTM)
-6.51%
Return on equity (TTM)
-44.72%
Valuation
Price to book
0.18
Price to tangible book (TTM)
0.18
Price to free cash flow (TTM)
-0.894
Free cash flow yield (TTM)
-111.87%
Free cash flow per share (TTM)
-0.644
Growth
Earnings per share change (TTM)
-186.91%
3-year earnings per share growth (CAGR)
132.13%
10-year earnings per share growth (CAGR)
-15.54%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.